JP5483880B2
(ja)
*
|
2006-10-23 |
2014-05-07 |
武田薬品工業株式会社 |
イミノピリジン誘導体およびその用途
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
AU2008279447A1
(en)
|
2007-07-19 |
2009-01-29 |
Metabolex, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
|
US20110039892A1
(en)
*
|
2008-04-23 |
2011-02-17 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivative and use thereof
|
US8481569B2
(en)
*
|
2008-04-23 |
2013-07-09 |
Takeda Pharmaceutical Company Limited |
Iminopyridine derivatives and use thereof
|
US20090270393A1
(en)
*
|
2008-04-23 |
2009-10-29 |
Takeda Pharmaceutical Company Limited |
Iminopyridine Derivatives and Use Thereof
|
AU2013206248B2
(en)
*
|
2008-06-27 |
2016-06-23 |
Xenon Pharmaceuticals Inc. |
Organic compounds
|
PL2344474T3
(pl)
|
2008-09-02 |
2016-03-31 |
Novartis Ag |
Pochodne pikolinamidu jako inhibitory kinaz
|
AU2011265439B2
(en)
*
|
2008-09-02 |
2012-09-20 |
Novartis Ag |
Picolinamide derivatives as kinase inhibitors
|
RU2011123647A
(ru)
|
2008-11-10 |
2012-12-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Соединения, полезные в качестве ингибиторов atr киназы
|
US8232273B2
(en)
*
|
2008-12-19 |
2012-07-31 |
Genentech, Inc. |
Heterocyclic compounds and methods of use
|
SG172248A1
(en)
|
2008-12-19 |
2011-07-28 |
Vertex Pharma |
Pyrazine derivatives useful as inhibitors of atr kinase
|
PA8852901A1
(es)
|
2008-12-22 |
2010-07-27 |
Lilly Co Eli |
Inhibidores de proteina cinasa
|
EP2424843B1
(en)
*
|
2009-04-30 |
2014-03-26 |
Novartis AG |
Imidazole derivatives and their use as modulators of cyclin dependent kinases
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
ES2497566T3
(es)
|
2009-10-01 |
2014-09-23 |
Cymabay Therapeutics, Inc. |
Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida
|
JP5833022B2
(ja)
*
|
2010-01-27 |
2015-12-16 |
エービー・ファーマ・リミテッド |
C型肝炎ウィルス阻害剤としてのポリ複素環式化合物
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
MA34234B1
(fr)
*
|
2010-04-07 |
2013-05-02 |
Hoffmann La Roche |
Composes pyrazol-4-yl-heterocyclyle-carboxamide et leurs procedes d'utilisation
|
EP2569287B1
(en)
|
2010-05-12 |
2014-07-09 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
EP2569284B1
(en)
|
2010-05-12 |
2015-07-08 |
Vertex Pharmaceuticals Incorporated |
2-aminopyridine derivatives useful as inhibitors of atr kinase
|
WO2011143419A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazines useful as inhibitors of atr kinase
|
US9062008B2
(en)
|
2010-05-12 |
2015-06-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2011143399A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
CA2798763A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2011149874A2
(en)
*
|
2010-05-26 |
2011-12-01 |
Schering Corporation |
N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
|
NZ605627A
(en)
|
2010-06-23 |
2015-06-26 |
Vertex Pharma |
Pyrrolo-pyrazine derivatives useful as inhibitors of atr kinase
|
CA2802541A1
(en)
|
2010-06-23 |
2011-12-29 |
Metabolex, Inc. |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
US20130109682A1
(en)
*
|
2010-07-06 |
2013-05-02 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
WO2012035421A2
(en)
|
2010-09-17 |
2012-03-22 |
Purdue Pharma L.P. |
Pyridine compounds and the uses thereof
|
CA2813704A1
(en)
|
2010-10-05 |
2012-04-12 |
Purdue Pharma L.P. |
Quinazoline compounds as sodium channel blockers
|
US8987307B2
(en)
|
2011-03-03 |
2015-03-24 |
Hoffmann-La Roche Inc. |
3-amino-pyridines as GPBAR1 agonists
|
UY33930A
(es)
*
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Inhibidores novedosos de quinasas
|
WO2012138938A1
(en)
|
2011-04-05 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazine compounds useful as inhibitors of tra kinase
|
WO2012178125A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2012178123A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2723747A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
CN102924445B
(zh)
*
|
2011-08-11 |
2015-07-08 |
上海吉铠医药科技有限公司 |
Pim激酶抑制剂及其制备方法与在制药中的应用
|
US9345705B2
(en)
|
2011-09-15 |
2016-05-24 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
SG2014012579A
(en)
*
|
2011-09-27 |
2014-04-28 |
Hoffmann La Roche |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
US8853217B2
(en)
|
2011-09-30 |
2014-10-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
US8846686B2
(en)
|
2011-09-30 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
CN103957917A
(zh)
|
2011-09-30 |
2014-07-30 |
沃泰克斯药物股份有限公司 |
用atr抑制剂治疗胰腺癌和非小细胞肺癌
|
US8765751B2
(en)
|
2011-09-30 |
2014-07-01 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
EP3878851A1
(en)
|
2011-09-30 |
2021-09-15 |
Vertex Pharmaceuticals Incorporated |
Process for making compounds useful as inhibitors of atr kinase
|
EP2776419B1
(en)
|
2011-11-09 |
2016-05-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
WO2013071094A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
US8846917B2
(en)
|
2011-11-09 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
US8841337B2
(en)
|
2011-11-09 |
2014-09-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
EP2776420A1
(en)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
JP6382108B2
(ja)
*
|
2011-11-30 |
2018-08-29 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
新規二環式ジヒドロイソキノリン−1−オン誘導体
|
PL2833973T3
(pl)
|
2012-04-05 |
2018-02-28 |
Vertex Pharmaceuticals Incorporated |
Związki użyteczne jako inhibitory kinazy ATR i ich terapie skojarzone
|
BR112014028954A2
(pt)
|
2012-05-21 |
2017-07-18 |
Novartis Ag |
amidas de n-piridinila substituídas no anel como inibidores da quinase
|
BR112015004284A2
(pt)
|
2012-08-30 |
2017-07-04 |
Nippon Shinyaku Co Ltd |
derivado de piridina e medicina
|
EP2904406B1
(en)
|
2012-10-04 |
2018-03-21 |
Vertex Pharmaceuticals Incorporated |
Method for measuring atr inhibition mediated increases in dna damage
|
WO2014062604A1
(en)
|
2012-10-16 |
2014-04-24 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
BR112015012454B1
(pt)
|
2012-12-07 |
2022-07-05 |
Vertex Pharmaceuticals Incorporated |
Compostos inibidores de atr quinase, seu uso e composição farmacêutica compreendendo os mesmos
|
CN103058913B
(zh)
*
|
2012-12-13 |
2015-09-30 |
江苏弘和药物研发有限公司 |
5-氯异吲哚酮的合成方法
|
WO2014110574A1
(en)
*
|
2013-01-14 |
2014-07-17 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
|
KR102403306B1
(ko)
|
2013-01-15 |
2022-06-02 |
인사이트 홀딩스 코포레이션 |
Pim 키나제 저해제로서 유용한 티아졸카복스아마이드 및 피리딘카복스아마이드 화합물
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
US9663519B2
(en)
|
2013-03-15 |
2017-05-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
MY182082A
(en)
|
2013-05-01 |
2021-01-18 |
Hoffmann La Roche |
Biheteroaryl compounds and uses thereof
|
WO2014181813A1
(ja)
*
|
2013-05-10 |
2014-11-13 |
武田薬品工業株式会社 |
複素環化合物
|
US9556197B2
(en)
|
2013-08-23 |
2017-01-31 |
Incyte Corporation |
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
|
AU2014345594B2
(en)
*
|
2013-11-05 |
2018-11-08 |
Bayer Cropscience Aktiengesellschaft |
Substituted benzamides for the treatment of arthropods
|
SG11201604519PA
(en)
|
2013-12-06 |
2016-07-28 |
Vertex Pharma |
2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
|
US10730866B2
(en)
*
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
EP3152212B9
(en)
|
2014-06-05 |
2020-05-27 |
Vertex Pharmaceuticals Inc. |
Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof
|
WO2015195740A1
(en)
|
2014-06-17 |
2015-12-23 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of chk1 and atr inhibitors
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
US9822124B2
(en)
|
2014-07-14 |
2017-11-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
WO2016024350A1
(ja)
*
|
2014-08-13 |
2016-02-18 |
株式会社エス・ディー・エス バイオテック |
縮合11員環化合物及びそれらを含有する農園芸用殺菌剤
|
UY36294A
(es)
|
2014-09-12 |
2016-04-29 |
Novartis Ag |
Compuestos y composiciones como inhibidores de quinasa
|
US10202365B2
(en)
|
2015-02-06 |
2019-02-12 |
Blueprint Medicines Corporation |
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
HUE053067T2
(hu)
|
2015-07-16 |
2021-06-28 |
Array Biopharma Inc |
Helyettesített pirazolo[1,5-A]piridin vegyületek, mint RET kináz inhibitorok
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
US11464774B2
(en)
|
2015-09-30 |
2022-10-11 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
TW201718546A
(zh)
|
2015-10-02 |
2017-06-01 |
英塞特公司 |
適用作pim激酶抑制劑之雜環化合物
|
RU2744852C2
(ru)
|
2015-10-26 |
2021-03-16 |
Локсо Онколоджи, Инк. |
Точечные мутации в устойчивых к ингибитору trk злокачественных опухолях и связанные с ними способы
|
HRP20231681T1
(hr)
|
2015-11-02 |
2024-04-12 |
Blueprint Medicines Corporation |
Inhibitori za ret
|
US11903387B2
(en)
|
2016-02-08 |
2024-02-20 |
Gowan Company, L.L.C. |
Fungicidal composition
|
JP6407457B2
(ja)
|
2016-02-08 |
2018-10-17 |
株式会社エス・ディー・エス バイオテック |
1,2−ベンゼンジメタノール化合物の製造方法
|
MA44612A
(fr)
|
2016-04-04 |
2019-02-13 |
Loxo Oncology Inc |
Méthodes de traitement de cancers pédiatriques
|
WO2017176751A1
(en)
|
2016-04-04 |
2017-10-12 |
Loxo Oncology, Inc. |
Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
CN107286134B
(zh)
*
|
2016-04-11 |
2019-04-12 |
上海勋和医药科技有限公司 |
2,4-二取代嘧啶衍生物作为cdk抑制剂及其应用
|
JP7443057B2
(ja)
|
2016-05-18 |
2024-03-05 |
ロクソ オンコロジー, インコーポレイテッド |
(S)-N-(5-((R)-2-(2,5-ジフルオロフェニル)ピロリジン-1-イル)-ピラゾロ[1,5-a]ピリミジン-3-イル)-3-ヒドロキシピロリジン-1-カルボキサミドの調製
|
WO2018017983A1
(en)
|
2016-07-22 |
2018-01-25 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to ret
|
US10035789B2
(en)
|
2016-07-27 |
2018-07-31 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
EP3493807A1
(en)
|
2016-08-03 |
2019-06-12 |
CymaBay Therapeutics, Inc. |
Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
US10752609B2
(en)
|
2016-11-28 |
2020-08-25 |
Bristol-Myers Squibb Company |
GSK-3 inhibitors
|
CN110198934B
(zh)
*
|
2016-11-28 |
2022-07-22 |
百时美施贵宝公司 |
作为gsk-3抑制剂的嘧啶甲酰胺
|
WO2018136661A1
(en)
|
2017-01-18 |
2018-07-26 |
Andrews Steven W |
SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS RET KINASE INHIBITORS
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
EP3461480A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
|
TWI812649B
(zh)
|
2017-10-10 |
2023-08-21 |
美商絡速藥業公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
|
TWI791053B
(zh)
|
2017-10-10 |
2023-02-01 |
美商亞雷生物製藥股份有限公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
|
AU2018352695A1
(en)
|
2017-10-19 |
2020-05-28 |
Effector Therapeutics, Inc. |
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
|
CN107641095A
(zh)
*
|
2017-11-16 |
2018-01-30 |
常州合全药业有限公司 |
一种7‑甲氧基异吲哚‑1‑酮的合成方法
|
AR113922A1
(es)
|
2017-12-08 |
2020-07-01 |
Incyte Corp |
Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
|
CA3087972C
(en)
|
2018-01-18 |
2023-01-10 |
Array Biopharma Inc. |
Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors
|
WO2019143991A1
(en)
|
2018-01-18 |
2019-07-25 |
Array Biopharma Inc. |
SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS AS RET KINASE INHIBITORS
|
WO2019143977A1
(en)
|
2018-01-18 |
2019-07-25 |
Array Biopharma Inc. |
Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
|
PL3755703T3
(pl)
|
2018-02-20 |
2022-11-07 |
Incyte Corporation |
Pochodne n-(fenylo)-2-(fenylo)pirymidyno-4-karboksyamidu i związki pokrewne jako inhibitory hpk1 do leczenia nowotworu
|
PL3762368T3
(pl)
|
2018-03-08 |
2022-06-06 |
Incyte Corporation |
ZWIĄZKI AMINOPIRAZYNODIOLOWE JAKO INHIBITORY PI3K-γ
|
SI3773589T1
(sl)
|
2018-04-03 |
2024-03-29 |
Blueprint Medicines Corporation |
Inhibitor RET za uporabo pri zdravljenju raka, ki ima RET spremembo
|
WO2020010003A1
(en)
|
2018-07-02 |
2020-01-09 |
Incyte Corporation |
AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
|
CA3224945A1
(en)
|
2018-07-31 |
2020-02-06 |
Loxo Oncology, Inc. |
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
TW202024020A
(zh)
*
|
2018-08-29 |
2020-07-01 |
美商錫爾羅克醫療公司 |
治療神經退化性疾病之方法
|
JP2022500383A
(ja)
|
2018-09-10 |
2022-01-04 |
アレイ バイオファーマ インコーポレイテッド |
Retキナーゼ阻害剤としての縮合複素環式化合物
|
US11142525B2
(en)
*
|
2018-11-15 |
2021-10-12 |
Pfizer Inc. |
Azalactam compounds as HPK1 inhibitors
|
US20220081438A1
(en)
|
2018-12-19 |
2022-03-17 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases
|
EP3898615A1
(en)
|
2018-12-19 |
2021-10-27 |
Array Biopharma, Inc. |
7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer
|
AU2020326703A1
(en)
|
2019-08-06 |
2022-02-17 |
Incyte Corporation |
Solid forms of an HPK1 inhibitor
|
KR20220123023A
(ko)
|
2019-12-27 |
2022-09-05 |
슈뢰딩거, 인크. |
시클릭 화합물 및 이의 사용 방법
|
CN111592533B
(zh)
*
|
2020-06-16 |
2021-08-24 |
浙江工业大学 |
1,2,4-噁二唑联吡啶取代苯甲酰胺类化合物及其制备方法和应用
|
US20230365584A1
(en)
|
2020-09-10 |
2023-11-16 |
Schrödinger, Inc. |
Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancer
|
US20240148732A1
(en)
|
2021-01-26 |
2024-05-09 |
Schrödinger, Inc. |
Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders
|
TW202300150A
(zh)
|
2021-03-18 |
2023-01-01 |
美商薛定諤公司 |
環狀化合物及其使用方法
|
KR20240037184A
(ko)
*
|
2021-04-16 |
2024-03-21 |
핫스팟 세라퓨틱스, 인크. |
화합물, 조성물 및 암 치료 방법
|
WO2023030478A1
(zh)
*
|
2021-09-03 |
2023-03-09 |
浙江海正药业股份有限公司 |
吡啶并内酰胺类衍生物及其制备方法和用途
|
WO2023088435A1
(zh)
*
|
2021-11-19 |
2023-05-25 |
成都奥睿药业有限公司 |
三取代吡啶衍生物的制备及作为芳香烃受体调节物的应用
|
WO2023250399A1
(en)
*
|
2022-06-22 |
2023-12-28 |
Tempest Therapeutics, Inc. |
Trex1 inhibitors and uses thereof
|